A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different Ways

NCT06520514 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Boehringer Ingelheim